We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




No Link Found Between Fertility Drugs and Cancer

By HospiMedica staff writers
Posted on 28 Jan 2002
A study has found that use of fertility drugs does not put women at a higher-than-average risk of ovarian cancer. More...
The research was conducted by investigators at the University of Pittsburgh Graduate School of Public Health (GSPH, PA, USA) and was published in the February 1, 2002, issue of the American Journal of Epidemiology.

The study suggests that some women who receive fertility treatments develop ovarian cancer because of underlying conditions that cause infertility, not because of the treatments. The investigators analyzed data on the use of fertility drugs among 5,207 women with ovarian cancer and 7,705 women without ovarian cancer. Results showed that women who spent more than five years trying to conceive had a 2.7-fold higher risk for ovarian cancer than those who tried for less than one year. Women who used fertility drugs were no more likely to develop ovarian cancer than those who never used fertility drugs. The risk of ovarian cancer dropped with each pregnancy.

The infertile women who were the most likely to develop ovarian cancer were those whose infertility resulted from endometriosis or from unknown causes. The researchers found that ovarian cancer was not associated with the following causes of infertility: ovulation or menstrual problems, ovarian cysts, blocked tubes, uterine development problems, or cervical mucous and/or inflamed cervix.

"This analysis helps put to rest the questions that have been troubling physicians and the women who endure arduous fertility treatments,” said Roberta Ness, M.D., M.P.H., principal investigator and professor of epidemiology at the GSPH.




Related Links:
University of Pittsburgh Medical Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.